TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphomaQinghong Li, Hongyuan Liang, Kunming Zhang et al.|PLoS ONE|2024Cited by 0